SERCA Enzymes as Targets for Polycystic Kidney Disease

SERCA enzymes have emerged as potential therapeutic targets for Polycystic Kidney Disease (PKD), a prevalent hereditary kidney disease estimated to affect over 12 million people worldwide.

Written by
Anna Tzani
  • Categories
  • Target Selection
Receive the latest newsletter directly to your inbox

Polycystic Kidney Disease (PKD)

Lack of a Cure for ADPKD

Uncovering Targets for ADPKD

SERCA Enzymes as Targets for Polycystic Kidney Disease image 0
Figure 1: Dendrogram view of targets for ADPKD studied in vitro sorted by evidence score.

Most evidence: PKD1 gene

Emerging Targets: SERCA Enzymes

Conclusion

References

More on Target Selection